IRIS Accounts Production v25.2.0.378 SC568340 Board of Directors 1.7.23 31.12.24 31.12.24 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC5683402023-06-30SC5683402024-12-31SC5683402023-07-012024-12-31SC5683402022-06-30SC5683402022-07-012023-06-30SC5683402023-06-30SC568340ns15:Scotland2023-07-012024-12-31SC568340ns14:PoundSterling2023-07-012024-12-31SC568340ns10:Director12023-07-012024-12-31SC568340ns10:PrivateLimitedCompanyLtd2023-07-012024-12-31SC568340ns10:SmallEntities2023-07-012024-12-31SC568340ns10:AuditExempt-NoAccountantsReport2023-07-012024-12-31SC568340ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-12-31SC568340ns10:SmallCompaniesRegimeForAccounts2023-07-012024-12-31SC568340ns10:FullAccounts2023-07-012024-12-31SC568340ns10:Director22023-07-012024-12-31SC568340ns10:RegisteredOffice2023-07-012024-12-31SC568340ns5:CurrentFinancialInstruments2024-12-31SC568340ns5:CurrentFinancialInstruments2023-06-30SC568340ns5:Non-currentFinancialInstruments2024-12-31SC568340ns5:Non-currentFinancialInstruments2023-06-30SC568340ns5:ShareCapital2024-12-31SC568340ns5:ShareCapital2023-06-30SC568340ns5:RetainedEarningsAccumulatedLosses2024-12-31SC568340ns5:RetainedEarningsAccumulatedLosses2023-06-30SC56834012023-07-012024-12-31SC568340ns5:FurnitureFittings2023-07-012024-12-31SC568340ns5:MotorVehicles2023-07-012024-12-31SC568340ns5:FurnitureFittings2023-06-30SC568340ns5:MotorVehicles2023-06-30SC568340ns5:FurnitureFittings2024-12-31SC568340ns5:MotorVehicles2024-12-31SC568340ns5:FurnitureFittings2023-06-30SC568340ns5:MotorVehicles2023-06-30SC568340ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31SC568340ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-30
REGISTERED NUMBER: SC568340 (Scotland)














REPORT OF THE DIRECTORS AND

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024

FOR

THE DEARING CLINIC LTD

THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024




Page

Company Information 1

Report of the Directors 2

Balance Sheet 3

Notes to the Financial Statements 5


THE DEARING CLINIC LTD

COMPANY INFORMATION
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024







DIRECTORS: J Dearing
Mrs S L Dearing





REGISTERED OFFICE: Highlees Farm
Old Loans Road
Dundonald
Ayrshire
KA2 9DD





REGISTERED NUMBER: SC568340 (Scotland)





ACCOUNTANTS: Henry Brown & Co
Chartered Accountants
26 Portland Road
Kilmarnock
Ayrshire
KA1 2EB

THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)

REPORT OF THE DIRECTORS
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024

The directors present their report with the financial statements of the company for the period 1 July 2023 to 31 December 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 July 2023 to the date of this report.

J Dearing
Mrs S L Dearing

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





J Dearing - Director


3 July 2025

THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 53,119 67,869
Investments 6 111,426 110,798
Investment property 7 271,416 271,416
435,961 450,083

CURRENT ASSETS
Debtors 8 24,083 83
Cash at bank 306,548 219,181
330,631 219,264
CREDITORS
Amounts falling due within one year 9 129,823 67,940
NET CURRENT ASSETS 200,808 151,324
TOTAL ASSETS LESS CURRENT
LIABILITIES

636,769

601,407

CREDITORS
Amounts falling due after more than one
year

10

-

(20,000

)

PROVISIONS FOR LIABILITIES (12,895 ) (12,895 )
NET ASSETS 623,874 568,512

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 623,872 568,510
623,874 568,512

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 July 2025 and were signed on its behalf by:





J Dearing - Director


THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024

1. STATUTORY INFORMATION

The Dearing Clinic Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Depreciation
Depreciation of tangible fixed assets has been based on estimated useful lives and residual values deemed appropriate by the directors. Estimated useful lives and residual values are reviewed annually and revised as appropriate.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures and fittings - 33% on cost
Motor vehicles - 20% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024

3. ACCOUNTING POLICIES - continued

Financial instruments
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Financial assets classified as receivable within one year are not amortised.

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date. Any impairment loss is recognised in the profit and loss account. Subsequent reversals are reversed and recognised in the profit and loss but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Financial liabilities classified as payable within one year are not amortised.

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024

3. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Investments
Investments are recorded are historic cost, gains or losses are recorded when these are crystallised.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 4 (2023 - 4 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 July 2023 313 167,140 167,453
Additions - 33,265 33,265
Disposals - (55,790 ) (55,790 )
At 31 December 2024 313 144,615 144,928
DEPRECIATION
At 1 July 2023 313 99,271 99,584
Charge for period - 21,199 21,199
Eliminated on disposal - (28,974 ) (28,974 )
At 31 December 2024 313 91,496 91,809
NET BOOK VALUE
At 31 December 2024 - 53,119 53,119
At 30 June 2023 - 67,869 67,869

6. FIXED ASSET INVESTMENTS

Investments (neither listed nor unlisted) were as follows:
2024 2023
£    £   
Wine futures 111,426 110,798

THE DEARING CLINIC LTD (REGISTERED NUMBER: SC568340)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024

7. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 July 2023
and 31 December 2024 271,416
NET BOOK VALUE
At 31 December 2024 271,416
At 30 June 2023 271,416

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 24,083 83

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 8,089 10,000
Trade creditors - 1,517
Taxation and social security 118,522 51,062
Other creditors 3,212 5,361
129,823 67,940

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans - 20,000

11. ULTIMATE CONTROLLING PARTY

The controlling party is J Dearing.

The ultimate controlling party is J Dearing.